Vasa Denticity Limited (NSE: DENTALKART) is a New Delhi, Delhi-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹797 Cr, it ranks #1,718 by market cap among the 6,197 Indian listed companies on FinBizNet, and #5 of 13 in Pharmaceutical Product Distribution. At ₹458.00 (as of 16 Nov 2026), the share price is 25.2% below its 52-week high of ₹612.00 and 42.0% above its 52-week low of ₹322.50. The share price is down 21.4% over one year and up 21.9% over three months.
| Current Price | ₹458.00 |
|---|---|
| Market Cap | ₹797 Cr |
| NSE Symbol | DENTALKART |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 76.5 |
| Return on Equity | 6.68% |
| Return on Assets | 3.18% |
| 52-Week Range | ₹322.50 – ₹612.00 |
| 1-Year Price Change | -21.4% |
| 3-Month Price Change | +21.9% |
| Beta (1Y) | -0.15 |
| Headquarters | New Delhi, Delhi |
| Website | www.dentalkart.com |
| Revenue | ₹87 Cr |
|---|---|
| Net Profit | ₹5 Cr |
| Net Margin | 6.0% |
| EPS (Basic) | ₹2.97 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Promoters held 59.65% of Vasa Denticity Limited's shares as of Sept 2026, against 65.60% in Sept 2025 (−5.95 percentage points).
Vasa Denticity Limited trades in and distributes dental products, instruments, equipment, and consumables to dental clinics, hospitals, and practitioners in India. The company provides general dentistry products, pharmacy, hand sanitizers, student section, restorative, endodontics, orthodontics, oral surgery, paedodontics, prosthodontics, periodontics, implantology, patient education models, sterilization, laboratory, new clinic setup kit, clinical problem solver, and medical supplies. It sells its products through Dentalkart.com, an online portal and Dentalkart online store. The company was incorporated in 2016 and is based in New Delhi, India.
1. Dental Products-This segment engages in the trading of dental products. 2. NA-NA 3. NA-NA 4. NA-NA
1. Dental Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Entero Healthcare Solutions Limited | ₹8,733 Cr | 74.6 | 8.28% | ₹2,087 Cr | +80.7% |
| Remus Pharmaceuticals Limited | ₹941 Cr | 26.1 | 13.78% | — | +0.6% |
| Health X Platform Limited (Sastasundar Ventures Ltd) | ₹871 Cr | 752.7 | -0.18% | ₹484 Cr | -5.7% |
| Aptus Pharma Limited | ₹837 Cr | 156.8 | — | — | +754.0% |
| Vasa Denticity Limited | ₹797 Cr | 76.5 | 6.68% | ₹87 Cr | -21.4% |
| Bijoy Hans Ltd | ₹523 Cr | — | — | — | +128.4% |
| Speciality Medicines Limited | ₹149 Cr | 11.5 | — | — | — |
| Vijaypd Ceutical Limited | ₹136 Cr | 23 | 9.53% | — | — |
| Royal Sense Limited | ₹39 Cr | 5.6 | — | — | -71.2% |
Listed by market capitalisation. Ratios are shown for context only.
Vasa Denticity Limited is trading at ₹458.00, with a market capitalisation of ₹797 Cr.
Vasa Denticity Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Vasa Denticity Limited has a P/E of 76.5 and a return on equity of 6.68%.
Vasa Denticity Limited is listed on the NSE under the symbol DENTALKART.
Vasa Denticity Limited's share price is down 21.4% over one year and up 21.9% over three months. Its 52-week range is ₹322.50 to ₹612.00.
In Q2 FY27, Vasa Denticity Limited reported revenue of ₹87 Cr and net profit of ₹5 Cr, with basic EPS of ₹2.97 (consolidated, parsed from the company's exchange filing).
Promoters held 59.65% of Vasa Denticity Limited's shares as of Sept 2026, against 65.60% in Sept 2025 (−5.95 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.